Authors: K. Linhartová; L. Riedlbauchová Authors‘ workplace: Kardiologická klinika 2. LF UK a FN Motol, Praha Published in: Kardiol Rev Int Med 2011, 13(4): 225-227
Tachycardia-induced cardiomyopathy appears to be a possibly not very rare clinical event, characterised by a reversible disorder of the systolic function of the ventricles with signs of cardiac failure based on chronic or even intermittent tachyarrythmia. In the therapeutic approach, a key role is played, alongside the treatment of cardiac failure, by the normalisation, or at least adequate control of cardiac rhythm, preferably by non-pharmacological treatment, which leads to restoration of the systolic function of the ventricles, generally within weeks.
Keywords: cardiomyopathy – supraventricular tachyarrhythmias – radiofrequential ablation
1. Riedlbauchová L. Kardiomyopatie indukovaná tachykardií. In: Veselka J, Linhartová K, Zemánek D et al (eds). Kardiomyopatie. Praha: Galén 2009 : 139–143.
2. Umana E, Solares CA, Alpert MA. Tachycardia-induced cardiomyopathy. Review. Am J Med 2003; 114 : 51–55.
3. Shinbane JS, Wood MA, Jensen DN et al. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol 1997; 29 : 709–715.
4. Lishmanov A, Chockalingam P, Senthilkumar A et al. Tachycardia-Induced Cardiomyopathy: Evaluation and Therapeutic Options. Congest Heart Fail 2010; 16 : 122–126.
5. Khasnis A, Jongnarangsin K, Abela G et al. Tachycardia-induced cardiomyopathy: a review of literature. Pacing Clin Electrophysiol 2005; 28 : 710–721.
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
